CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis by Salao, K et al.
RESEARCH ARTICLE
CLIC1 regulates dendritic cell antigen processing and
presentation by modulating phagosome acidification and
proteolysis
Kanin Salao1,‡, Lele Jiang1,*,‡, Hui Li1, Vicky W.-W. Tsai1, Yasmin Husaini1, Paul M. G. Curmi2, Louise J. Brown3,
David A. Brown1,‡ and Samuel N. Breit1,‡,§
ABSTRACT
Intracellular chloride channel protein 1 (CLIC1) participates in
inflammatory processes by regulating macrophage phagosomal
functions such as pH and proteolysis. Here, we sought to
determine if CLIC1 can regulate adaptive immunity by actions on
dendritic cells (DCs), the key professional antigen presenting cells.
To do this, we first generated bone marrow-derived DCs (BMDCs)
from germline CLIC1 gene-deleted (CLIC1−/−) and wild-type
(CLIC1+/+) mice, then studied them in vitro and in vivo. We found
phagocytosis triggered cytoplasmic CLIC1 translocation to the
phagosomal membrane where it regulated phagosomal pH and
proteolysis. Phagosomes from CLIC1−/− BMDCs displayed impaired
acidification and proteolysis, which could be reproduced if CLIC1+/+,
but not CLIC1−/− cells, were treated with IAA94, a CLIC family ion
channel blocker. CLIC1−/− BMDC displayed reduced in vitro antigen
processing and presentation of full-length myelin oligodendrocyte
glycoprotein (MOG) and reduced MOG-induced experimental
autoimmune encephalomyelitis. These data suggest that CLIC1
regulatesDC phagosomal pH to ensure optimal processing of antigen
for presentation to antigen-specific T-cells. Further, they indicate that
CLIC1 is a novel therapeutic target to help reduce the adaptive
immune response in autoimmune diseases.
KEY WORDS: CLIC1, Dendritic cells, Phagosome, Acidification,
Proteolysis, Antigen presentation
INTRODUCTION
Antigen presentation is a multiple step processes by which antigen
presenting cells (APCs), including macrophages and dendritic cells
(DCs), ingest, process and present exogenous antigens, in a complex
with MHC class II molecules, to T-cells. APCs first internalize
antigen via either endocytosis or phagocytosis, then undertake at
least two distinct proteolytic steps. For presentation to CD4 T-cells,
there is proteolysis of the antigen and processing of MHC-bound
invariant chain (li) to form the class II associated invariant chain
peptide (CLIP). If uptake is via phagocytosis, proteolysis of the
antigen is initiated by endopeptidases, to fragment the native
protein. This is followed by sequential trimming of the peptide ends
by amino and carboxypeptidases. This helps to generate small
peptides that have the required lengths of 18-20 amino acids (Blum
and Cresswell, 1988; Deussing et al., 1998) to sit in the antigen
binding groove on MHC class II molecules. Simultaneously, the
invariant chain of MHC II undergoes selective proteolytic cleavage
of li, which occupies the antigen binding groove. This cleavage
event allows for exogenous peptide loading and formation of the
MHC II-peptide complex (Busch et al., 2005; Cresswell, 1996),
which is then transported to the plasma membrane of APCs.
The major professional APCs are DCs. For DCs to be able to
present antigen effectively, following antigen ingestion, they must
next undergo maturation (Chow et al., 2002). This can be triggered
by activation stimuli from substances including conserved
components of microorganisms or pathogen-associated molecular
pattern molecules (PAMPs) such as lipopolysaccharide (LPS).
PAMPs are recognized by pattern recognition receptors (PRRs) of
the innate immune system such as Toll-like receptors (TLRs).
Activation of PRR signalling in DCs results in inhibition of further
endocytosis or phagocytosis of antigens, upregulation of expression
of MHCII molecules and their transport to the cell surface and
upregulation of expression of cytokines and costimulatory
molecules such as CD40, CD80 and CD86 that are necessary for
effective T-cell activation (Trombetta and Mellman, 2005).
Activation and clonal expansion of naïve CD4+ T-cells by DCs
involves binding of the T-cell receptors (TCR) to MHC II bound
antigen on DCs, coupled with binding of the DC expressed
costimulatory molecule B7 (CD80/86) to CD28 on T-cells (Huppa
and Davis, 2003). In addition, signals provided by distinct cytokines
program naïve CD4+ T-cells into different T helper (TH) subsets
including Th1 cells. Activated TH1 cells express high levels of
intracellular interferon gamma (IFNγ) which is commonly used for
flow cytometric detection of T-cell activation, because it is rapidly
induced (16 h) after encounter with antigen presented by DCs
(Mosmann et al., 1986).
Many studies have demonstrated that proteolysis is an
indispensable requirement for effective antigen presentation by
DCs (Deussing et al., 1998; Hsing and Rudensky, 2005; Shi et al.,
1999). This proteolysis is driven by proteases that reside in the
phagosomal or endosomal compartments and function optimally in
a defined pH environment. The cathepsins, a class of proteases that
are comprised of cysteine and aspartyl proteases, are especially
important in processing of peptide for presentation by MHC class II
molecules. Most cysteine proteases are unstable and have weak
activity at neutral pH and only function optimally in acidicReceived 8 March 2016; Accepted 29 March 2016
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phagosomal compartments. Thus, efficient antigen processing is a
highly pH-dependent process.
Unlike macrophages and neutrophils, DCs have developed a
more tightly regulated mechanism to sustain their phagosomal pH
environment so that peptides are not fully degraded. It is widely
accepted that acidification and reactive oxygen species (ROS)
production are the two key elements in this regulation. Acidification
is mainly, but not exclusively, mediated by the vacuolar ATPase (V-
ATPase), which translocate protons from the cytosol into the
phagosome lumen (Cross and Segal, 2004). Further, immature DCs
have less efficient phagosomal acidification due to limited
recruitment of the V-ATPase to lysosomes, as compared to
macrophages or mature DCs (Trombetta et al., 2003). Another
mechanism that mediates acidification in DCs is the production of
ROS from NADPH oxidase 2 (NOX2) leading to an enzymatic
multiprotein complex. This multiprotein complex requires the early
Rab27a dependent recruitment of gp91phox to the phagosomal
membrane (Elsen et al., 2004). Rab27a is believed to regulate DC
phagosome pH as Rab27a deficient DCs have a delay in the
recruitment of NOX2 to the phagosome, resulting in increased
phagosomal acidification and antigen degradation, the consequence
of which is a defect in antigen presentation (Jancic et al., 2007).
Further evidence for the involvement of NOX2 and ROS production
in antigen presentation came from work in Vav-deficient DCs. Vav,
a member of the guanine nucleotide exchange factor (GEF) family,
catalyses the exchange of bound GDP to GTP on Rac, another early
component of the NOX2 complex (Crespo et al., 1997). Vav-
deficient DCs also showed a decrease in phagosomal pH, an
increase in antigen degradation and consequently failed to present
antigen efficiently (Jancic et al., 2007; Rybicka et al., 2010). It is
believed that the NOX2 complex in DCs produce low levels of
ROS, resulting in sustained alkalization of the phagosomal lumen
and consequent inefficient antigen processing (Savina et al., 2006).
Recently, we have discovered that intracellular chloride channel
protein 1 (CLIC1) regulates macrophage phagosomal pH (Jiang
et al., 2012) and thus may also play a role in pH regulation of similar
structures in DCs. CLIC1, a member of the evolutionarily conserved
6 member CLIC family of chloride ion channel proteins, was first
cloned because of its expression in activated macrophages
(Valenzuela et al., 1997). Its gene is located in the MHC class III
region of chromosome 6 (Littler et al., 2004) near the gene for TNF-
alpha, suggesting a potential role in regulation of immune and
inflammatory responses. All protein members of the CLIC family
are relatively small in sizewith only a single putative transmembrane
region (Jiang et al., 2014). They are unusual, as they exist in both
soluble cytoplasmic and integral membrane forms (Valenzuela
et al., 1997). CLIC proteins have to undergo a major structural
rearrangement to transform from their glutathione-S transferase
(GST)-like structure in the soluble form to that of an integral
membrane protein (Goodchild et al., 2009; Littler et al., 2004).
In resting macrophages, CLIC1 resides in uncharacterized
cytoplasmic vesicle-like structures. Upon phagocytosis, CLIC1
rapidly translocates to the phagosomal membrane, where it is co-
locatedwith othermembrane proteins like the RhoGTPases, Rac and
RhoA, as well as NADPH oxidase components (Jiang et al., 2012).
Using live cell imaging, we have found that CLIC1−/−macrophages
display impaired phagosome acidification and proteolysis suggesting
that CLIC1 may directly regulate phagosomal acidification and as a
consequence also proteolysis (Jiang et al., 2012).
Whilst the phagosomal pH of macrophages and DCs are different,
they both relyonphagosomal acidification to help regulate proteolysis,
which, in DCs, is essential for antigen processing and presentation. In
this study we have investigated the role of CLIC1 in regulating these
events in bone marrow dendritic cells (BMDCs). We show that in
resting BMDCs, CLIC1 is widely distributed in the cytoplasm in
punctate vesicle-like structures similar to those we have previously
identified inmacrophages (Jiang et al., 2012). Shortly after initiationof
phagocytosis CLIC1 moves to the BMDC phagosomal membrane
where it can be seen with the membrane protein RhoA. Further, we
show thatCLIC1−/−BMDCs have an elevated phagosomal pHwhich
leads to reduced phagosomal proteolysis, the end result of which is
reduced in vivo and in vitro antigen presentation.
RESULTS
CLIC1 is present on BMDC phagosomal membranes
To determine the subcellular localization of CLIC1 in BMDCs, we
have used immunofluorescence confocal microscopy. BMDCs were
fixed and stained with an affinity purified sheep polyclonal
antibody to murine CLIC1 and a rabbit anti-murine RhoA,
followed by a cy3- and cy2-labelled anti-sheep and anti-rabbit
IgG, respectively. In restingCLIC1+/+ BMDCs, CLIC1 staining was
punctate (Fig. 1B) in a pattern similar to that we have previously
described in macrophages (Jiang et al., 2012). There was a similar
staining pattern for the ras homolog family member A (RhoA),
which did not co-localise with CLIC1 (Fig. 1A-C). As expected no
CLIC1 staining could be identified in CLIC1−/− control cells
(Fig. 1G-I). To determine whether CLIC1 translocates to
phagosomal membranes, 5 min after they had undergone
synchronised phagocytosis of IgG opsonized zymosan particles,
we fixed then stained BMDCs. RhoA appears on the phagosomal
membrane at 5 min (Fig. 1F, arrow), as it is known to do. At the
same time point CLIC1 also appears on the phagosome membrane
where is partially colocalises with RhoA (Fig. 1D-F). As expected,
in CLIC1−/− control cells, whilst RhoA staining was present, no
CLIC1 antibody staining was detectable (Fig. 1J-L).
Phagosomes from CLIC1−/− BMDCs display impaired
acidification
The localization of CLIC1 to phagosomal membranes suggests that
it may regulate phagosomal pH in BMDCs. To investigate this, we
monitored the process of phagosomal acidification using live cell
imaging of CLIC1+/+ and CLIC1−/− BMDCs that had undergone
synchronized phagocytosis of IgG opsonised zymosan particles
labelled with the pH sensitive dye FITC (zFITC) (Jiang et al., 2012).
FITC can effectively differentiate pH values between about 5.5 and
7.5 (Fig. S1) (Chen et al., 2008).
After synchronised phagocytosis, the phagosome of CLIC1+/+
and CLIC1−/− BMDCs slowly acidified (Fig. 2A) with consequent
decrease in FITC fluorescence of the phagocytosed particle. The
rate of decrease in phagosomal pH of CLIC1+/+ and CLIC1−/−
BMDCs started to diverge at about 7 min after phagocytosis. From
7-14 min, the CLIC1−/− phagosomal pH clearly dropped more
slowly than that of CLIC1+/+ BMDC phagosomes. Between 15 and
30 min, the phagosomal pH reached a steady state and over this
period, the average phagosomal pH of the CLIC1−/− cells was
higher than that of CLIC1+/+ cells (Fig. 2B, n=6/group with 10-15
zymosan containing phagosomes analysed per experiment; P=0.02,
two-way repeated-measures ANOVA). These results show that
phagosomes from CLIC1−/− BMDCs have impaired acidification.
TheCLIC1 ionchannel blocker IAA94raisesthepHofCLIC1+/+
but not CLIC1−/− BMDC phagosomes
CLIC1 gene deletion in BMDC leads to impaired phagosome
acidification. To help further verify that the impaired acidification
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was directly due to CLIC1 gene deletion, we treated both CLIC1+/+
andCLIC1−/−BMDCswith IAA94, a small molecule blocker of the
CLIC family of ion channels, then monitored phagosomal pH as
described above. The average steady state pH of IAA94 treated
CLIC1−/−BMDCs, calculated based on the average pH between 15-
30 min after synchronized phagocytosis, did not differ significantly
from untreated CLIC1−/− BMDCs [Fig. 2B; pH 6.02±0.05 vs
5.97±0.01 (mean±s.e.m.), n=3/group with 10-15 zymosan
containing BMDCs analysed per experiment; P=0.564, paired t-
test]. However, IAA94 treatment of CLIC1+/+ BMDCs significantly
raised their average phagosomal pH from 5.63±0.07 to 6.02±0.11
(Fig. 2B; n=3/group with 10-15 zymosan containing BMDCs
analysed per experiment; P=0.03, paired t-test). Additionally, the
pH of these IAA94 treatedCLIC1+/+ BMDCs was not different from
that of CLIC−/− BMDCs (Fig. 2B; pH 5.99±0.03 vs 6.02±0.05,
n=3/group with 10-15 zymosan containing BMDCs analysed per
experiment; P=0.648, paired t-test). These data indicate that the
altered phagosomal pH of CLIC1−/− BMDCs is likely to be a direct
consequence of gene deletion, and that in our experimental system,
the pH effect of IAA94 is due to its specific blockade of CLIC1.
CLIC1−/− BMDC display impaired phagosomal proteolysis
Whilst the difference in phagosomal pH between CLIC1+/+ and
CLIC1−/− BMDCs is modest, this difference may impact on highly
pH-dependent processes such as proteolysis. To directly examine
this hypothesis, we used live cell imaging to monitor real time
proteolysis in BMDC that had engulfed 3 µm silica beads (Jiang
et al., 2012; Yates and Russell, 2008), to which had been coupled
Alex Fluor 594 as a reference dye and DQ bodipy BSA as a
substrate. The latter becomes more fluorescent as its self-quenching
is reduced by proteolysis (Santambrogio et al., 1999). Loosely
adhered CLIC1+/+ and CLIC1−/− BMDCs underwent synchronized
phagocytosis with the labelled silica beads, which were then
monitored by live cell imagining for 60 min. The graph of the
Fig. 1. Phagocytosis triggers CLIC1
translocation to BMDC phagosomal
membrane. (A-F) Immunofluorescence
confocal microscopic images of resting
CLIC1+/+ BMDCs (A-C) or BMDCs
phagocytosing IgG-opsonised zymosan
particles (D-F), stained with antibodies to
RhoA (green) or CLIC1 (red). (G-L) Images
of resting CLIC1−/− BMDCs (G-I) or BMDCs
phagocytosing IgG-opsonised zymosan
particles (J-L), stained with antibodies to
RhoA (green) and CLIC1 (red). Both CLIC1
and RhoA appear on the phagosomal
membrane after 5 min of phagocytosis in
CLIC1+/+ BMDCs (F, arrows). Only RhoA
can be identified on the phagosomal
membrane of CLIC1−/− BMDCs (L, arrows).
Scale bar: 10 µm.
622









 by guest on September 14, 2017http://bio.biologists.org/Downloaded from 
change in the fluorescence signal clearly indicates that CLIC1+/+
BMDCs proteolyse BSA much faster than CLIC1−/− BMDCs
(Fig. 3; n=6/group with 15-20 silica bead containing BMDCs
analysed per experiment; P=0.005, two-way repeated-measures
ANOVA). These rate differences indicate that CLIC1-mediated
alteration in phagosomal acidification is also associated with
impaired proteolysis in BMDC phagosomes. As proteolysis is a
key step in DC antigen presentation, this may have consequences for
T-cell activation.
CLIC1−/−BMDCactivate fewer T-cellswhena large peptide is
used as antigen
CLIC1 gene deletion attenuates both DC phagosomal acidification
and proteolysis, one consequence of which may be altered DC
mediated T-cell activation. To investigate this, we examined the
capacity of BMDCs to present myelin oligodendrocyte
glycoprotein (MOG) antigen to CD4+ T-cells from 2D2 mice
which express a transgenic MOG35-55 peptide-specific TCR
(Bettelli et al., 2003). However, 2D2 mice are on a C57BL/6
background whilst CLIC1−/− and control CLIC1+/+ mice are on a
129X1/SVJ background. Further, as the gene for CLIC1 is in the
MHC class III region (Lehner et al., 2004), these mice could not be
backcrossed to alter their genetic background to that of C57BL/6.
However, C57BL6 and 129X1/SVJ have the same MHCII I-Ab/I-
Enull haplotype, which suggests that they may be compatible for
our in vitro antigen presentation studies. To ensure that, under the
conditions of our experiments, no unwanted reactivity was directed
by or to 129X1/SVJ cells, we performed a cell mixing experiment.
CD4+ T-cells were purified from 2D2 mouse spleens using
magnetic beads coated with monoclonal antibody to CD4 and were
incubated then with BMDCs from 129X1/SVJ or C57BL/6 mice at
a ratio of 1:2 BMDC:T-cell for 16 h, with Golgi stop being added
for the final 4 h. Activated T-cells, were identified by flow
cytometry as CD3+CD4+CD45hiVβ11+ cells (Fig. S2B) that also
stained for intracellular INFγ (Fig. S3A). When 129X1/SVJ
BMDCs were mixed with 2D2 T-cells, in the absence of antigen,
we could identify no difference in T-cell activation from that of
C57BL/6 BMDCs (Fig. S3C; 1.43±0.25 vs 1.47±0.34, n=3/group;
P=0.69, unpaired t-test). To further confirm there are no
unwanted responses, T-cells were also labelled with antibody
to CD25/CD69 T-cell activation markers (Fig. S3B). Consistent
with INFγ responses, in absence of antigen, there was no
evidence of T-cell activation in 129X1/SVJ and C57BL/6
cell mixing experiments (Fig. S3D; 3.77±0.33 vs 4.27±0.20,
n=3/group; P=0.27, unpaired t-test). These results exclude any
artefact from alloreactivity between 129X1/SVJ BMDC and
C57BL/6 2D2 T-cells in our assay format.
To examine the effect of CLIC1 on antigen processing and
presentation, CLIC1−/− or CLIC1+/+ BMDCs were to aliquoted into
a 96 well plate to which was then added 1.25 pmoles/well of the 21
amino acid MOG peptide MOG35-55 or 1.25 pmoles/well of full
length recombinant MOG1-125 peptide. After incubation of the
peptides with BMDCs for various time periods, the cells were
washed after which BMDCs were matured and antigen processing
stopped by the addition of LPS 0.1 µg/ml for 4 h. MOG-specific
2D2 T-cells (2×105/well) were then added for a further 16 h during
which the last 4 h of incubation were in the presence of Golgi stop
(1 µg/ml). Activated transgenic T-cells, was then determined by
staining for intracellular IFNγ and analysis using multiparameter
flow cytometry (Fig. S2B, Fig. S4).
When MOG35-55 peptide, that requires no processing to be
presented via MHCII was used as an antigen, CLIC1−/− and
CLIC1+/+ BMDCs activated similar proportions of T-cells at all
time points (Fig. 4A; n=6/group with triplicate samples per time
point in each experiment; P=0.21; two-way repeated-measures
ANOVA). However, when BMDCs were pulsed with MOG1-125,
which does require processing for presentation, CLIC1−/−
BMDCs activated significantly fewer T- cells at all time points
than CLIC1+/+ BMDCs (Fig. 4B; n=6/group with triplicate
samples per time point in each experiment; P=0.0001, two-way
repeated-measures ANOVA). This indicated that if antigen
processing is required, CLIC1−/− BMDCs present antigen less
well than CLIC1+/+ BMDCs and suggested a potential role for
CLIC1 in regulating antigen processing and presentation, which
may be mediated, at least in part, by modulation of pH and
proteolysis.
Fig. 2. CLIC1−/− BMDCs display impaired phagosome acidification. Live
BMDCs that had undergone synchronised phagocytosis of an IgG-opsonised
zymosan particle covalently coupled with a pH-sensitive fluorescent probe,
in the presence or absence of IAA94 (100 μM), were monitored continuously
for 30 min using an inverted Zeiss Axiovert 200 M microscope. (A) The
phagosomal pH ofCLIC1−/− BMDCs was higher than that ofCLIC1+/+ BMDCs
over the 30 min time course. (B) IAA94 treatment had no effect on the steady
state phagosomal pH of CLIC1−/− BMDCs, but impaired the acidification of
CLIC1+/+ BMDC phagosomes to the same level as that of CLIC1−/− BMDCs.
Data represents mean±s.e.m. analysed using two-way repeated-measures
ANOVA or paired t-test respectively.
Fig. 3. CLIC1−/− BMDCs display impaired phagosome proteolysis. Live
BMDCs that had undergone synchronised phagocytosis of 3 µm silica beads,
covalently coupled with DQ-bodipy BSA and Alexa Fluor 594, were
continuously monitored for 60 min using an inverted Zeiss Axiovert 200M
microscope. The time course of proteolytic activity within the phagosome,
measured as gain of fluorescence, showed that CLIC1+/+ BMDCs were more
efficient in BSA proteolysis than CLIC1−/− BMDCs. Data represents mean±
s.e.m. analysed using two-way repeated-measures ANOVA.
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The antigen processing inhibitor chloroquine reduces T-cell
activation of a large peptide antigen in CLIC1+/+ BMDC
Efficient activation of T-cells by large peptide antigens requires
both DC antigen processing and presentation to T-cells. To further
differentiate these two interdependent processes, we used
chloroquine, which inhibits antigen processing by raising the
phagosome pH whilst still preserving antigen presentation
(Lewinsohn et al., 1998). Using essentially the same experimental
procedure as above, CLIC1−/− or CLIC1+/+ BMDCs were
preincubated with 100 µl of culture medium containing 100 mM
chloroquine. After 1 h, the 21 amino acid MOG35-55 peptide or full
length recombinant MOG1-125 were added to the culture for various
time periods after which the cells were matured, 2D2 T-cells were
added and the cells stained with the same antibody panel as above,
to assess activation of MOG reactive 2D2 T-cells.
When BMDCs were incubated with MOG35-55, which requires
little or no processing for efficient antigen presentation, a similar
fold increase in activated T-cells were found in CLIC1−/− and
CLIC1+/+BMDCs, independent of chloroquine treatment (Fig. 5A;
n=3/group with triplicate samples per time point in each experiment,
P=0.15, two-way repeated-measures ANOVA). However, when
BMDCs were incubated with full length MOG1-125 peptide, which
requires antigen processing for effective antigen presentation, the
proportion of activated T-cells was very low and similar after
incubation with vehicle- or chloroquine-treated CLIC1−/− BMDC
(Fig. 5B; n=3/group with triplicate samples per time point in each
experiment, P=0.069, two-way repeated-measures ANOVA).
Further, antigen presentation by chloroquine-treated CLIC1+/+
BMDCs was similar to that of the CLIC1−/− BMDC but was
much lower than that of vehicle-treated CLIC1+/+ BMDCs (Fig. 5B;
n=3/group with triplicate samples per time point in each experiment;
P=0.001, two-way repeated-measures ANOVA). These data further
support the hypothesis that CLIC1 is acting to modify antigen
processing and therefore reducing the substrate for antigen
presentation.
The CLIC1 ion channel blocker IAA94 diminishes T-cell
activation in CLIC1+/+ but not CLIC1−/− BMDCs
To further confirm that CLIC1 gene deletion directly caused the
defect in antigen processing, we examined the effect of the CLIC1
chloride ion channel blocker IAA94 (Kim et al., 2004; Pope et al.,
1991) on antigen process and presentation. Using essentially the
same experimental procedure as above, CLIC1−/− or CLIC1+/+
BMDCs were preincubated in culture medium containing vehicle or
100 mM of IAA94. After 1 h, MOG35-55 or MOG1-125 was added to
the culture for 4 h after which the cells were matured, 2D2 T-cells
were then added and 16 h later, and the cells were stained with the
same antibody panel as above, for flow cytometric evaluation of
2D2 T-cell activation.
Similar to chloroquine, IAA94 did not modify T-cell activation
following MOG35-55 presentation by either CLIC1
+/+ or CLIC1−/−
BMDCs (Fig. 6A; n=3/group with triplicate samples per time point
in each experiment; P=0.367, two-way repeated-measures
ANOVA). In contrast, when presenting MOG1-125, T-cell
activation was reduced when CLIC1+/+ BMDCs were treated with
IAA94 (Fig. 6B; n=3/group with triplicate samples per time point in
each experiment; P=0.003, two-way repeated-measures ANOVA).
IAA94 treatment of CLIC1+/+ BMDCs reduced T-cell activation to
the same level as vehicle-treated CLIC1−/− BMDCs (Fig. 6B; n=3/
group with triplicate samples per time point in each experiment;
P=0.282, two-way repeated-measures ANOVA). As expected,
IAA94 treatment of MOG1-125-pulsed CLIC1
−/− BMDCs did not
alter their capacity to activate T-cells. These data indicate that, by
acting specifically on CLIC1, the ion channel blocker IAA94 acts to
Fig. 5. Chloroquine reduces CD4+ T-cell activation by MOG1-125-pulsed
CLIC1+/+ but not CLIC1−/− BMDCs. The proportion of activated (intracellular
IFNγ-containing) MOG-specific 2D2 CD4+ T-cells after 16 h coculture with
chloroquine (100 μM) treated or untreated BMDCs pulsed with (A) 1.25 pmoles
of the short MOG35-55 peptide or with (B) equimolar full length MOG1-125. Fold
increase in activated T-cells was calculated relative to the no antigen control.
Data, representing mean±s.e.m., were analysed using two-way repeated-
measures ANOVA.
Fig. 6. IAA94 reduces CD4+ T-cell activation by MOG1-125-pulsed CLIC1
+/+
but not CLIC1−/− BMDCs. The proportion of activated (intracellular IFNγ-
containing) MOG-specific 2D2 CD4+ T-cells after 16 h coculture with IAA94
(100 μM) treated or untreated BMDCs pulsed with (A) 1.25 pmoles of the short
MOG35-55 peptide or with (B) equimolar full length MOG1-125. Fold increase in
activated T-cells was calculated relatively to the no antigen control. Data
representing mean±s.e.m. were analysed using two-way repeated-measures
ANOVA.
Fig. 4. Antigen-pulsed CLIC1−/− BMDCs have a reduced capacity to
activate CD4+ T-cells. The proportion of activated (intracellular IFNγ-
containing) MOG-specific 2D2 CD4+ T-cells after 16 h coculture with BMDCs
pulsed with (A) 1.25 pmoles of the short MOG35-55 peptide or (B) with
equimolar full length MOG1-125. The fold increase in activated T-cells was
calculated relatively to the no antigen control. Data, representingmean±s.e.m.,
were analysed using two-way repeated-measures ANOVA.
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reduce DC-mediated T-cell activation to MOG1-125 which requires
processing but not to MOG35-55, which requires no processing.
Reduced T-cell activation by CLIC1−/− BMDCs is not due to
altered expression of costimulatory molecules
DC maturation is critical for effective antigen presentation to T-
cells, in part because it results in an expression of important
costimulatory molecules (De Smedt et al., 1996; Michelsen et al.,
2001). To determine if the reduced T-cell activation found on
CLIC1−/− BMDCs was due to decreases in costimulatory molecule
expression, we assessed BMDCs expression of CD40, CD80 and
CD86. We also investigated BMDC expression of MHC class II,
which is essential for antigen presentation to T-cells. CLIC1−/− and
CLIC1+/+ BMDCs (1×105/well) were dispensed into a 96-well
plates and then incubated for 4 h with LPS at a concentration of
either 0.1, 0.0001 or 0.00001 µg/ml. BMDCs were then washed and
stained with antibodies to CD45, CD3, CD11c, CD40, CD80, CD86
and MHC class II. Although expression of these markers was
significantly increased with increasing LPS concentration, therewas
no significant difference in expression of any of these surface
markers between CLIC1+/+ and CLIC1−/− BMDCs at any LPS
concentration (Fig. 7A-D). This indicates that deletion of CLIC1
gene has no effect on DC expression of CD40, CD80, CD86 and
MHC class II and is consistent with the notion that the primary
defect is antigen processing, rather than antigen presentation.
CLIC1−/−BMDCpresentingMOG1-125 induce less EAEdisease
Our data strongly indicates that CLIC1 deletion has an effect on
BMDC processing of peptide, resulting in a reduced in vitro capacity
to activate CD4+ T-cells. To determine whether these changes could
also be demonstrated in vivo, we studied murine experimental
autoimmune encephalomyelitis (EAE), an established model of
multiple sclerosis (Constantinescu et al., 2011). We induced disease
in groups of six CLIC1+/+ and six CLIC1−/− age- and sex-matched
mice with CLIC1+/+ or CLIC1−/− BMDCs which had been pulsed
with MOG1-125 and then matured with LPS. The cells were injected
subcutaneously (s.c.) into both flanks of CLIC1+/+ and CLIC1−/−
mice. One and 3 days later, the animals were also injected with
200 ng of pertussis toxin, which is part of the usual protocol for
MOG vaccination-induced EAE (Constantinescu et al., 2011). This
microbial product is thought to promote EAE development by
facilitating the migration of pathogenic T-cells to the CNS
(Hofstetter et al., 2002). The mice were observed daily, in a
blinded manner, and disease scores were assigned based on awidely
used clinical scoring scale (Constantinescu et al., 2011) ranging
from 1 for verymild disease (flaccid tail) to 5 for complete paralysis.
From days 9-17, in the disease development phase of EAE,
MOG1-125-pulsed CLIC1
−/− BMDCs in CLIC1−/− mice elicited
less severe EAE than MOG1-125-pulsed CLIC1
+/+ BMDCs in
CLIC1+/+ mice (Fig. 8A; n=6/group; P=0.003, two-way repeated-
measures ANOVA). Immunisation of CLIC1+/+ mice with
MOG1-125-pulsed CLIC1
−/− or CLIC1+/+ BMDCs lead to
essentially identical EAE disease severity (Fig. 8B; n=6/group;
P=0.222, two-way repeated-measures ANOVA). HoweverCLIC1−/−
mice immunised with MOG1-125-pulsed CLIC1
−/− BMDCs
compared to CLIC1+/+ BMDCs, in the disease development
phase, displayed less severe EAE disease that fell just short of
statistical significance (Fig. 8C; n=6/group; P=0.064, two-way
repeated-measures ANOVA). Overall, these data indicate that
CLIC1−/− mice have milder EAE disease, and that there is likely
to be a reduced capacity of CLIC1−/− BMDCs to elicit the initial
local response, before secondary amplification of the immune
response occurs at more distal sites.
DISCUSSION
We have found that upon BMDC phagocytosis of an opsonised
particle, cytoplasmic CLIC1 rapidly translocates to the phagosomal
membrane where it partially colocalises with RhoA, a known
phagosome membrane-associated protein. Whilst CLIC1 is on the
phagosome membrane, the studies in this manuscript cannot
determine if it is an integral or a peripheral membrane protein.
However, from this location it regulates phagosomal pH and
proteolysis. Whilst CLIC1 modulation of proteolysis is likely to be
related to alteration in phagosomal pH, by what means it is altered
by CLIC1 is less clear. The most obvious explanation for
the increased BMDC phagosomal pH in CLIC1−/− mice is lack
of CLIC1 chloride ion channel activity on the phagosomal
surfaces. Supporting this view is the previous published data
demonstrating CLIC protein ion channel activity (Littler et al.,
2010b) and in this study, that the CLIC ion channel blocker IAA94
limited phagosome acidification inCLIC1+/+ BMDCs (Fig. 2B) and
impaired their in vitro antigen presentation capacity, but had
no effect on those functions in CLIC1−/− BMDCs (Fig. 6B),
indicating that IAA94’s actions are specific for CLIC1. Lack of
CLIC1-mediated chloride influx would be expected to lead to
higher pH values.
Fig. 7. CLIC1 has no effect on LPS-
induced BMDC activation cell surface
molecules. The percentage of BMDCs
expressing cell surface MHC class II or
costimulatory molecules after 4 h incubation
with escalating doses of LPS was measured
using flow cytometry. There was no
significant difference between CLIC1+/+ and
CLIC1−/− BMDCs in the proportion of
BMDCs expressing CD40 (A), CD86 (B),
CD80 (C) or MHC class II molecules (D) for
any LPS dose. Data representing mean±
s.e.m. were analysed using unpaired t-tests.
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Phagocytosis results in progressive phagosomal acidification, an
important component of which is V-ATPase proton pump H+ influx
(Feske et al., 2015). As part of this process chloride ions are needed
for charge compensation and many lines of evidence from several
groups suggests that CLIC proteins can behave as chloride ion
channels (reviewed in Littler et al., 2010b). More recently it has also
been shown that mutating key residues in the putative
transmembrane domain of CLIC1 markedly modifies its ion
channel properties (Averaimo et al., 2013). Further, under
oxidizing conditions soluble CLIC1 undergoes a major structural
rearrangement (Littler et al., 2004) and in the presence ofmembranes
with cholesterol, monomeric CLIC1 oligomerised to form a pore
(Goodchild et al., 2011; Valenzuela et al., 2013). These all suggest
that after insertion into a membrane, CLIC1 can form ion channel
pores and behave as a chloride ion channel. However, whether
CLICs are ion channels is controversial, to a large extent because
structural studies of solubleCLICs do not resemble any conventional
ion channels but belong to the GST fold superfamily of proteins
(Cromer et al., 2007; Harrop et al., 2001; Littler et al., 2005, 2010a)
and display glutaredoxin-like glutathione-dependent oxidoreductase
enzymatic activity (Al Khamici et al., 2015) and to date, there are no
high-resolution structures of the membrane form of CLICs that
provide evidence as to how they are able to conduct chloride ions.
CLIC1 might also alter phagosomal pH if it played a role in the
phagosome-lysosome fusion. After phagocytosis, phagosomes
progressively acidify in parallel with their maturation during
which they fuse with other acidic organelles, thereby gaining
additional membrane and soluble constituents. The fusion process
often requires movement of the phagosomes along microtubules
where they can fuse with lysosomes, a process requiring actin
assembly at the phagosomal membrane (Blocker et al., 1997). Ezrin,
radixin and moesin (ERM) proteins provide a linkage between
integral membrane proteins and the actin cytoskeleton (Ivetic and
Ridley, 2004) and are downstream effectors of small GTPases
(Fehon et al., 2010), which play a part in phagosome–lysosome
fusion (Defacque et al., 2000; Erwig et al., 2006; Marion et al.,
2011). Whilst there is no direct evidence for CLIC1 in phagosome–
lysosome fusion, there are reports that several CLICs interact with
ERM. CLIC5 has been purified from placenta microvilli using
affinity chromatography with immobilised Ezrin (Berryman and
Bretscher, 2000) and in glomerular podocytes, CLIC5A co-
localises and can be co-immunoprecipitated with ERM (Pierchala
et al., 2010). CLIC4 is also found alongside Ezrin in apical
microvilli of retinal pigment epithelium (Chuang et al., 2010).
Perhaps the most direct evidences supporting CLIC’s role in
phagosome-lysosome fusion comes from studies, showing that
shortly after macrophage phagocytosis, CLIC3 couples to
cytoplasmic domain of a C3b transmembrane receptor (CRIg) on
phagosomal membranes which increases chloride conductance into
the phagosome lumen, and phagosome–lysosome fusion (Kim
et al., 2013). Similarly, in cancer cells, CLIC3 in the late endosome/
lysosome compartment works with Rab25 to facilitate recycling of
fibronectin binding integrins from late endosome/lysosome to
plasmamembrane (Dozynkiewicz et al., 2012). Whilst this evidence
suggests possible a roles for CLICs in phagosome maturation, using
sensitive methods, we have been unable to demonstrate alteration in
phagosome–lysosome fusion in CLIC1−/− macrophages, that as in
BMDCs, also display impaired acidification (Jiang et al., 2012).
Whilst the mechanism of CLIC1 action has not been completely
resolved, our studies indicate that phagosomes of CLIC1−/−
BMDCs, like macrophages (Jiang et al., 2012), display impaired
acidification and as a consequence, impaired proteolysis. In DCs,
important proteolytic enzymes such as cathepsin proteases and
IFNγ-inducible lysosomal thiolreductase (GILT) have actions that
are tightly regulated by local pH (Watts, 2012). Consistent with this,
Fig. 8. EAE disease clinical scores of mice immunised with MOG1-125-
pulsed BMDCs. EAE disease development, measured as clinical scores, was
blindly determined in mice immunised with full length MOG1-125-pulsed
BMDCs. EAE disease development was compared in (A) CLIC1−/− and
CLIC1+/+ mice immunised with MOG1-125-pulsed CLIC1
−/− and CLIC1+/+
BMDC respectively or (B) CLIC1+/+ mice immunised with MOG1-125-pulsed
CLIC1−/− or CLIC1+/+ BMDC or (C) CLIC1−/−mice immunised with MOG1-125-
pulsedCLIC1−/− orCLIC1+/+ BMDC. For analysis purposes, the clinical scores
have been separated into disease development stage (days 0 to 17) and
recovery phase (days 18 to 25) Data, representing mean±s.e.m. scores, were
analysed using two-way repeated-measures ANOVA.
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impairment of acidification in CLIC1−/− BMDC is associated with
impairment of antigen presentation of the large MOG1-125 peptide,
which requires processing, whilst having little effect on the small
MOG35-55 peptide that does not require processing. This impaired
antigen processing could result in reduced adaptive immune
responses due to attenuated T-cell responses. To test if our
in vitro findings would translate into in vivo changes we used the
MOG-induced EAE model.
To study antigen presentation in vivo, we have modified the EAE
model by replacing standard immunisation with injection of mice
with antigen-pulsed BMDCs. The generation of EAE involves
initial antigen presentation in the regional lymph nodes followed by
systemic amplification of this immune response in the spleen.
Subsequently, there is antigen presentation in the cervical lymph
nodes prior to T-cell entry in the CNS (Mohammad et al., 2014).
When EAE is induced with CLIC1−/− antigen-pulsed BMDCs in
CLIC−/− mice there is complete absence of CLIC1 and disease is
reduced as expected, compared with the same situation where
CLIC1 is replete (Fig. 8A). However, when the same CLIC1−/−
BMDCs are used to induce EAE in CLIC1+/+ mice, the situation is
more complex. While the initial immune response is likely to be
attenuated by CLIC1−/− BMDCs, antigen presenting cells in the
regional lymph nodes, spleen and cervical lymph nodes have intact
CLIC1 and would be expected to present antigen competently,
diluting the effect of the initial attenuated immune response. In this
pathogenic sequence, it might be expected that normal antigen
presentation in the spleen and cervical lymph nodes might lead to
equivalent responses in CLIC1+/+ mice, as we have demonstrated
(Fig. 8B). However, when CLIC1+/+ BMDCs were used to induce
disease inCLIC1−/−mice, the initial immune responsewould not be
expected to be amplified. Further, differential initial immune
responses elicited by CLIC1−/− and CLIC1+/+ BMDCs would be
expected to be maintained through the impaired amplification
process resulting in differences in disease. Indeed we found that
CLIC1−/− mice injected with CLIC1−/− BMDCs developed less
EAE than those injected with CLIC1+/+ BMDCs, but this just failed
to reach significance (Fig. 8C; P=0.064). This is likely to be due to a
number of factors. The magnitude of disease is less in CLIC1−/−
mice presumably because of the impaired antigen presentation of
key myelomoncytic cell subtypes in these mice, including
macrophages and DC, which both contribute significantly to
disease (de Vos et al., 2002; Rawji and Yong, 2013). This
attenuated disease is likely to significantly reduce the power of our
experimental design to detect small differences in disease.
Nevertheless, in our experimental paradigm there was an almost
significant reduction in EAE between CLIC1-deficient- and replete
BMDC-induced disease (Fig. 8C), suggesting the likelihood of
reduced in vivo antigen presentation by CLIC1−/− BMDCs.
Apart from the processing of antigen itself, the impaired
phagosomal acidification found in CLIC1−/− BMDCs could
influence other steps in antigen presentation. Phagosomal
proteases are also critical for processing the MHC class II
invariant chain (Ii) (Hsing and Rudensky, 2005). However, this is
unlikely as Ii processing is required for transport of MHC class II to
the cell surface (Fig. 7D) (Watts, 2012) and we found that MHC
class II expression was similar on the surface on CLIC1−/− and
CLIC1+/+ BMDC cell surface.
Another possible way by which deletion of CLIC1 could result in
reduced T-cell activation is by alteration in trafficking of vesicles
containing antigen bound MHC class II complexes (MHCII-p),
which must translocate to the cell surface for T-cell activation
(Roche and Furuta, 2015). However, again, this is unlikely to
explain the actions of CLIC1 because CLIC1+/+ and CLIC1−/−
BMDCs have similar cell surface staining for MHC class II BMDCs
(Fig. 7).
Our results suggest that in DC, CLIC1 regulates phagosomal pH
to ensure that the optimal conditions are present for effective antigen
processing and presentation and consequent adaptive immune
response activation. In the case of autoimmunity, where these
processes are dysregulated resulting in immune mediated tissue
destruction, CLIC1 may represent a novel therapeutic target.
MATERIALS AND METHODS
Chemicals and reagents
The affinity-purified rabbit polyclonal antibody to RhoA is from Abcam
(Cat #54853). All secondary antibodies are made in donkey and purchased
from Jackson ImmunoResearch Labs. Monoclonal antibodies for flow
cytometry were from Beckon Dickinson: anti-CD3-Pacific Blue (clone
1452C11, Cat #558214), anti-CD4-Alex Fluor 700 (clone GK1.5, Cat
#557956), anti-CD45-PerCP (clone 30F11, Cat #557235), anti-Vβ11-FITC
(clone RR3-15, Cat #553197), anti-CD25-APC-cy7 (clone PC61, Cat #),
anti-69-PE-cy7 (clone H1.2F3, Cat #552879), anti-CD86-Alexa Fluor 700
(clone GL1, Cat #560581), anti-CD80-FITC (clone 16-10A1, Cat #553768)
and anti-CD40-PE (clone 3/23, Cat #553791). Anti-I-A/I-E-FITC (clone
M5/114.15.2, Cat #107606) was from Biolegend and anti-IFNγ-PE-Cy7
(clone XMG1.2, Cat #25-7311-82) was from eBioscience. DAPI was from
Invitrogen (Cat #D3571). The short 21 amino acids (MOG35-55) and full
length 125 amino acid (MOG1-125) were from Prospec (Cat #PRO-371) and
Anaspec (Cat #55150-1000) respectively. Recombinant murine Flt3-ligand
(Flt3, Cat #250-31L), GM-CSF (Cat #315-03) and IL-4 (Cat #214-14) were
purchased from Peprotech.
Mice
All animal work was approved by the Garvan/St Vincent’s Hospital animal
ethics committee. The germ line gene deleted CLIC1−/− mice are on a
129X1/SVJ background and have been previously described (Qiu et al.,
2010). In all instances, syngeneic 129X1/SVJ mice or cells derived from
them were used as CLIC1+/+ control. 2D2 transgenic mice (C57BL/6
background) were kind gift from Dr Vijay Kuchroo (Harvard Medical
School, Boston, MA; Korn et al., 2007).
Cells and culture medium
All cells were cultured in RPMI-1640 (Cat #11875-093, Life Technologies)
containing 100 µg/ml Streptomycin (Cat #15140-122, Life Technologies),
2 mM L-glutamine (Cat #25030-081, Life Technologies), 50 µM
2-Mecaptoethanol, and 10% heat inactivated fetal calf serum FCS (Cat
#14190-250, Life Technologies). DCs were generated from bone
marrow cells as previously described (Mohammad et al., 2014). MOG
specific CD4+ T-cells were isolated from lymph nodes from 2D2 mice
and purified using magnetic beads as previously described (Mohammad
et al., 2014).
Zymosan preparation
Zymosan (Saccharomyces cervisiae) particles (Cat #Z4250, Sigma-
Aldrich) were boiled then washed twice in PBS. For opsonisation, 0.5 ml
of zymosan particles (14 mg/ml) were mixed with 0.5 ml purified goat IgG
(5 μg/ml) (Cat # I9140, Sigma-Aldrich) and incubated at 37°C for 30 min
(Jiang et al., 2012). To make FITC conjugated zymosan (zFITC) Zymosan
particles were incubated with FITC succinimidyl ester (1 mg/ml, Cat #F-
6185, Molecular Probes) (Jiang et al., 2012).
Bodipy conjugated silica beads
We covalently coupled 3.0 μm carboxylate-modified silica particles (Cat
#PSi-3.0COOH, Kisker Products for Biotechnologies) with Alexa Fluor
594 (R) carboxylic acid, succinimidyl ester (mixed isomers) (Alexa594-SE,
Cat #A20004, Molecular Probes) and DQ green bodipy bovine serum
albumin (DQ-bodipy BSA, Cat #D-12050, Molecular Probes), as described
previously (Jiang et al., 2012; Yates and Russell, 2008).
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Immunofluorescence confocal microscopy
Resting BMDCs or BMDCs 5 min after initiation of synchronised
phagocytosis were fixed with 4% paraformaldehyde (Cat #C004,
ProSciTech) on 8-chamber slides (Cat #354108, BD Biosciences), then
permeabilised with 0.05% saponin (Cat #S4521, Sigma-Aldrich) (Jiang
et al., 2012). After blocking with 2% IgG free BSA (Cat #001-000-161,
Jackson ImmunoResearch Labs) and 1 µg/ml Fc receptor blocking antibody
(Cat #553142, BD Biosciences), the cells were stained for; CLIC1 and
RhoA. Briefly, BMDCs were firstly stained with 1:100 rabbit anti-mouse
RhoA antibody then 1:100 donkey anti-rabbit Cy2 antibody (Cat#ab6940,
Abcam) followed by an in-house-derived 1:1000 sheep anti-mouse CLIC1
(Jiang et al., 2012), then 1:100 biotinylated donkey anti-sheep antibody (Cat
#713-065-003, Jackson ImmunoResearch Labs) and finally streptavidin
Cy3 (Cat#S6402, Sigma-Aldrich) (Jiang et al., 2012). Confocal images
were obtained on a Leica TCS SP confocal microscope (Leica
Microsystems, Germany) and processed using ImageJ64 (NIH, imagej.
nih.gov/ij/download/).
Intraphagosomal acidification measurement
This was undertaken essentially as previously described (Jiang et al., 2012).
Briefly, loosely adherent BMDCs on a fluordish (Cat #FD35-100, Coherent
Life Science), underwent synchronized phagocytosis (Jiang et al., 2012)
with opsonised zFITCs on the heated stage of microscope stage of a Zeiss
Axiovert 200M fluorescence microscope and the particle fluorescence was
recorded over 60 min, at a rate of one image per minute (excitation 490 nm,
emission 525 nm). In some instances, IAA94 (100 μM) (Cat #I117, Sigma-
Aldrich), a cell permeable CLIC1 ion channel blocker, Chloroquine (Cat
#C6628, Sigma-Aldrich) or DMSO (Cat #D2650, Sigma-Aldrich) were
added to the fluordish. To convert the excitation ratio to pH, time lapse
recordings over 45 min were carried out on BMDCs that had phagocytosed
opsonised zFITC, incubated in a series of buffers from pH 4 to pH 8 which
also contained bafilomycin A1 (100 nM), nigericin (10 µM), valinomycin
(10 µM) and carbonyl cyanide m-chlorophenylhydrazone (10 µM) to
disrupt membrane channel activity and allow equilibration of intracellular
pH with that of the extracellular buffer. There was minimal if any
photobleaching (Fig. S1A). A polynomial equation from this data was then
derived and used to convert the real time FITC intensity into pH units
(Fig. S1B).
Intraphagosomal proteolysis assay
This was performed essentially as previously described (Jiang et al., 2012).
In brief, loosely adherent BMDCs on a 42 mm glass coverslip (Cat
#CB00400RA1, Menzel-glaser), underwent synchronized phagocytosis
with DQ bodipy-conjugated silica beads on a heated microscope stage, as
above. The fluorescence intensities of calibration Alexa Fluor 594 dye
(excitation 570 nm, emission 620 nm) and green reporter DQ bodipy dye
(excitation 490 nm, emission 525 nm) were acquired over 60 min, at a rate
of one image per minute, as described above. The ratio of fluorescence
intensity of substrate to calibration fluorescencewas plotted against time and
used for ratiometric data analysis of intraphagosomal proteolysis.
Cell mixing experiment and flow cytometry
BMDCs (1×105; 100 μl) from 129X1/SVJ or C57BL/6 mice were mixed
with 100 μl of purified CD4+ T-cells (2×105) from 2D2 mice in wells of a U
bottom 96-well plate (Cat #353077, BD Biosciences) and incubated at 37°C
in 5% CO2 for 12 h. Golgi stop (1 µg/ml, Cat #554724, BD Biosciences)
was added 4 h prior to evaluation of intracellular cytokine staining. Cells
were then fixed, permeabilised (Cat #77-5775-40, eBioscience) then stained
for with anti-IFNγ-PE-Cy7. In separate experiments, 2D2 CD4+ T-cells
were also stained for cell surface activation markers using anti-CD25-APC-
Cy7 and anit-CD69-PE-Cy7. Flow cytometry data collection was performed
on an LSR II (BD Biosciences) and analysed using FlowJo software (Tree
Star Inc.).
In vitro T-cell activation
This was undertaken essentially as previously described (Mohammad et al.,
2014). Briefly, 1×105CLIC1+/+ orCLIC1−/−BMDCs in 100 µl of complete
medium were incubated with 1.25 pmoles of 21 amino acids MOG35-55 or
1.25 pmoles of 125 amino acids MOG1-125 peptides or vehicle for up to 4 h
at 37°C in 5% CO2 in a U bottom 96-well plate, in triplicate. The cells were
then washed, and LPSmatured after which transgenic 2D2 responder T-cells
were added and incubated for a further 16 h. The proportion of activated
2D2 T-cells (positive for CD4, Vβ11 and intracellular INFγ) were identified
by flow cytometry using the gating strategy described in Fig. S1B and data
were analysed using FlowJo software essentially as previously described
(Mohammad et al., 2014).
Costimulatatory molecule expression
1×106 BMDCs were resuspended into 200 µl complete medium in wells of a
U bottom plate containing LPS at 0.1 µg/ml, 0.0001 µg/ml or 0.00001 µg/
ml, for 4 h. BMDCs were then washed and stained with 1:100 dilution of
anti-CD11c-APC, anti-CD45-PerCP, anti-CD40-PE, anti-CD80-FITC,
anti-CD86-Alex700. Cells were also stained with anti-MHC class II-
FITC. All antibodies were from BD Biosciences. Appropriate compensation
and isotype controls were used. Flow cytometry data collection was
performed on an LSR II and analysed using FlowJo software essentially as
previously described (Mohammad et al., 2014).
EAE induction by antigen-pulsed BMDC
Female 8-12-week-old CLIC1+/+ and CLIC1−/− mice were injected
subcutaneously in both flanks 50 µl (1×106 cells) with live GM-CSF-
and IL-4-generated BMDCs that had been pulsed with 1.25 pmoles of
MOG1-125.
Myeloid DCswere generated from bonemarrow using GM-CSF and IL-4,
as described above. BMDCs were then resuspended in 5 ml of complete
medium and plated into wells of a 6-well plate (Cat #353046, BD
Biosciences) at 1×106 cell/ml. MOG1-125 (125 µg/ml; 1.25 pmoles) was
added to the cells for 4 h. Cells were washed three times with PBS to remove
any residue peptide. LPS (0.1 µg/ml) was added and cells were incubated for
another 4 h. These cells were washed and kept on ice at concentration of
1×106 cells in 50 µl. Female 8-12-week-old CLIC1+/+ and CLIC1−/− mice
were then injected subcutaneously in both flanks with 50 µl of these
BMDCs. Mice were subsequently injected intraperitoneally with 200 ng of
pertussia toxin (Cat #180, Sapphire Biosciences) in 0.2 ml PBS at 24 h and
3 days after injection of BMDCs. The mice were then observed daily in a
blinded manner, for clinical neurological signs and scores were assigned
based on the following widely used scale (Constantinescu et al., 2011) e.g.
scale; 1, flaccid tail; 2, hind limb weakness; 3, complete hind limb paralysis;
4, complete hind limb paralysis and forelimb paralysis; 5, complete paralysis.
Statistical analysis
All data were expressed as mean±s.e.m. Statistical comparisons were
performed using Student’s t-test or two-way repeated-measures ANOVA
and post-tested with Bonferroni. P-values <0.05 were considered to be
statistically significant. All data were analysed using GraphPad Prism 6.0
statistical software.
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